Variant report

Variant	esv3515257
Chromosome Location	chr5:177821096-177824769
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr5:177816543..177819082-chr5:177820341..177823036,2	K562	blood:

Extended variants
information (count: 109 )
Associated
traits (count: 101 )

Variant overlapped rSNPs/rCNVs (count:109 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs138500765	chr5:177821152-177821153	Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs545097308	chr5:177821155-177821156	Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs113918316	chr5:177821159-177821160	Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs553333486	chr5:177821185-177821186	Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs563757097	chr5:177821209-177821210	Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs575659691	chr5:177821242-177821243	Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs542973477	chr5:177821304-177821305	Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs144008620	chr5:177821331-177821332	Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs186162001	chr5:177821337-177821338	Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs375850130	chr5:177821344-177821345	Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs74770430	chr5:177821345-177821346	Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs112772311	chr5:177821393-177821394	Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs565467796	chr5:177821400-177821401	Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs116786077	chr5:177821446-177821447	Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs550893960	chr5:177821504-177821505	Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs568891680	chr5:177821530-177821531	Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs75431630	chr5:177821531-177821532	Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs147371417	chr5:177821539-177821540	Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs566372278	chr5:177821552-177821553	Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs374594899	chr5:177821558-177821559	Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs569009887	chr5:177821592-177821593	Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs533819388	chr5:177821598-177821599	Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs139563207	chr5:177821601-177821602	Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs576730607	chr5:177821641-177821642	Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs2973741	chr5:177821665-177821666	Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
26	rs556101028	chr5:177821669-177821670	Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs559033169	chr5:177821672-177821673	Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs371446866	chr5:177821675-177821676	Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs13435983	chr5:177821725-177821726	Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs201113561	chr5:177821775-177821776	Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs68142417	chr5:177821778-177821779	Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs542785626	chr5:177821833-177821834	Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Genic enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs141608536	chr5:177821846-177821847	Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Genic enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs111821264	chr5:177821906-177821907	Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Genic enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs368148997	chr5:177821914-177821915	Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Genic enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs540922707	chr5:177821958-177821959	Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Genic enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs561112852	chr5:177821975-177821976	Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Genic enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs13162581	chr5:177821984-177821985	Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Genic enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs113163496	chr5:177821994-177821995	Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Genic enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs79767871	chr5:177822072-177822073	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs111903226	chr5:177822082-177822083	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs56298603	chr5:177822148-177822149	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs111511403	chr5:177822160-177822161	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs111740307	chr5:177822170-177822171	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs537208292	chr5:177822248-177822249	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs565530372	chr5:177822307-177822308	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs532862066	chr5:177822308-177822309	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs551117897	chr5:177822557-177822558	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs56157917	chr5:177822587-177822588	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs113952584	chr5:177822591-177822592	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:101)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	16751803	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Glioma	20126413	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
Thyroid cancer	19087340	CNVD
Acute myeloid leukemia	20729466	CNVD
lymphocytic leukemia	21291569	CNVD
Multiple myeloma	17550852	CNVD
Salivary gland tumor	18059337	CNVD
Renal cell carcinoma	19377443	CNVD
Lung cancer	18438408	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Renal cell carcinoma	18592004	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Prostate cancer	18632612	CNVD
epilepsy	18472482	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Sotos syndrome	21572526	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Sotos syndrome	17561922	CNVD
Sotos syndrome	16773131	CNVD
Mental retardation	16773131	CNVD
Sotos syndrome	22470819	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Acute myeloid leukemia	18000384	CNVD
Sudden cardiac death	19188705	CNVD
Basal cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Olfactory neuroblastoma	18408657	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
abnormal development	18461090	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Lung cancer	17297452	CNVD
Cancer	20164920	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21509527	CNVD
Breast cancer	21804112	CNVD
Myelofibrosis	22110671	CNVD
Sotos syndrome	22283845	CNVD
Breast cancer	16272173	CNVD
Sotos syndrome	20503325	CNVD
Lung adenocarcinoma	17086460	CNVD
Congenital Hypertrichosis Syndrome	21636067	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Breast cancer	19181860	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Ehlers-danlos syndrome	17576883	CNVD
Lung cancer	17086460	CNVD
Autism	19246517	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:111 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:177811000-177821400	Enhancers	Fetal Thymus	thymus
2	chr5:177814400-177824000	Weak transcription	HUES48 Cell Line	embryonic stem cell
3	chr5:177814600-177824000	Weak transcription	ES-I3 Cell Line	embryonic stem cell
4	chr5:177817200-177823800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
5	chr5:177817400-177821200	Weak transcription	Right Ventricle	heart
6	chr5:177817600-177824000	Weak transcription	Left Ventricle	heart
7	chr5:177818600-177822000	Enhancers	Thymus	Thymus
8	chr5:177818800-177822000	Enhancers	Primary monocytes fromperipheralblood	blood
9	chr5:177819800-177824000	Weak transcription	HUES64 Cell Line	embryonic stem cell
10	chr5:177820000-177823800	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
11	chr5:177820200-177821400	Weak transcription	iPS-18 Cell Line	embryonic stem cell
12	chr5:177820200-177824000	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
13	chr5:177820400-177821400	Weak transcription	Cortex derived primary cultured neurospheres	brain
14	chr5:177820400-177821800	Enhancers	Primary neutrophils fromperipheralblood	blood
15	chr5:177820400-177823800	Weak transcription	Fetal Lung	lung
16	chr5:177820400-177824000	Weak transcription	iPS-20b Cell Line	embryonic stem cell
17	chr5:177820400-177824000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
18	chr5:177820400-177824000	Weak transcription	Spleen	Spleen
19	chr5:177820600-177821800	Enhancers	Monocytes-CD14+_RO01746	blood
20	chr5:177820800-177821800	Enhancers	H1 Cell Line	embryonic stem cell
21	chr5:177821000-177821200	Flanking Active TSS	Fetal Muscle Trunk	muscle
22	chr5:177821000-177821400	Enhancers	Lung	lung
23	chr5:177821000-177821600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
24	chr5:177821000-177821600	Enhancers	Skeletal Muscle Male	skeletal muscle
25	chr5:177821000-177821800	Enhancers	HUES6 Cell Line	embryonic stem cell
26	chr5:177821000-177821800	Bivalent Enhancer	Placenta	Placenta
27	chr5:177821000-177821800	Flanking Active TSS	HSMMtube	muscle
28	chr5:177821000-177822000	Flanking Bivalent TSS/Enh	Fetal Muscle Leg	muscle
29	chr5:177821000-177822000	Enhancers	Skeletal Muscle Female	skeletal muscle
30	chr5:177821200-177821400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
31	chr5:177821200-177821800	Enhancers	Right Ventricle	heart
32	chr5:177821200-177822000	Flanking Bivalent TSS/Enh	Fetal Muscle Trunk	muscle
33	chr5:177821400-177821800	Enhancers	iPS-18 Cell Line	embryonic stem cell
34	chr5:177821400-177821800	Bivalent Enhancer	Fetal Stomach	stomach
35	chr5:177821400-177821800	Enhancers	Psoas Muscle	Psoas
36	chr5:177821400-177822000	Enhancers	Cortex derived primary cultured neurospheres	brain
37	chr5:177821400-177822000	Genic enhancers	Fetal Thymus	thymus
38	chr5:177821400-177824000	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
39	chr5:177821600-177821800	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
40	chr5:177821600-177824000	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
41	chr5:177821800-177822000	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
42	chr5:177821800-177822000	Enhancers	Skeletal Muscle Male	skeletal muscle
43	chr5:177821800-177822000	Active TSS	HSMMtube	muscle
44	chr5:177821800-177823800	Weak transcription	Primary neutrophils fromperipheralblood	blood
45	chr5:177821800-177824000	Weak transcription	H1 Cell Line	embryonic stem cell
46	chr5:177821800-177824000	Weak transcription	iPS-18 Cell Line	embryonic stem cell
47	chr5:177821800-177824000	Weak transcription	Right Ventricle	heart
48	chr5:177821800-177826000	Weak transcription	HUES6 Cell Line	embryonic stem cell
49	chr5:177822000-177823800	Weak transcription	Cortex derived primary cultured neurospheres	brain
50	chr5:177822000-177823800	Weak transcription	Fetal Thymus	thymus

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links